Sandbox 121: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (16 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
=='''Modeling of Beta 2 Adrenergic Receptor: Ligand Binding and Activation'''== | =='''Modeling of Beta-2 Adrenergic Receptor: Ligand Binding and Activation'''== | ||
Students: Mary Acheampong, Kavita Bhikhi, Daviana Dueno, Bobby Glover, Lachoy Harris, Alafia Henry, Randol Mata, and Marisa Vanbrakle, Hostos-Lincoln Academy of Science | Students: Mary Acheampong, Kavita Bhikhi, Daviana Dueno, Bobby Glover, Lachoy Harris, Alafia Henry, Randol Mata, and Marisa Vanbrakle, Hostos-Lincoln Academy of Science | ||
| Line 5: | Line 5: | ||
Teacher: Allison Granberry, Hostos-Lincoln Academy of Science | Teacher: Allison Granberry, Hostos-Lincoln Academy of Science | ||
Mentors: Haregewein Assefa,Touro College of Pharmacy | Mentors: Thijs Beuming, Schrodinger, Haregewein Assefa,Touro College of Pharmacy | ||
---- | ---- | ||
| Line 12: | Line 12: | ||
The Beta-2 Adrenergic Receptor (B₂AR) is a G-protein coupled receptor (GPCR) which, when stimulated by a catecholamine, causes the relaxation of various smooth muscles, and the production of glucose by glycogenolysis and gluconeogenesis. Pharmaceuticals acting through B2AR are important for treating asthma, chronic obstructive pulmonary disease (COPD), and premature labor. The structure of B2AR consists of 7-transmembrane domains, connected by three extracellular loops and three intracellular loops. At the base of the extracellular loops, buried within the transmembrane helices, there is a predominately hydrophobic binding pocket with several crucial polar residues that interact with ligands. Interestingly, certain polar interactions appear to play a role in the conversion of the receptor from an active to an inactive state. Recent crystallography of B2AR has revealed that the active state, relative to the inactive state, shows only minor changes in the binding pocket, whereas critical shifts occur at the cytoplasmic face. These conformational changes lead to a dissociation of the G-protein from the receptor, which then initiates a signaling cascade. The Hostos-Lincoln Academy SMART team (Students Modeling A Research Topic) modeled ligands in complex with B2AR using 3D printing technology. Supported by grants from the HHMI Precollege Program and the Camille and Henry Dreyfus Foundation. | The Beta-2 Adrenergic Receptor (B₂AR) is a G-protein coupled receptor (GPCR) which, when stimulated by a catecholamine, causes the relaxation of various smooth muscles, and the production of glucose by glycogenolysis and gluconeogenesis. Pharmaceuticals acting through B2AR are important for treating asthma, chronic obstructive pulmonary disease (COPD), and premature labor. The structure of B2AR consists of 7-transmembrane domains, connected by three extracellular loops and three intracellular loops. At the base of the extracellular loops, buried within the transmembrane helices, there is a predominately hydrophobic binding pocket with several crucial polar residues that interact with ligands. Interestingly, certain polar interactions appear to play a role in the conversion of the receptor from an active to an inactive state. Recent crystallography of B2AR has revealed that the active state, relative to the inactive state, shows only minor changes in the binding pocket, whereas critical shifts occur at the cytoplasmic face. These conformational changes lead to a dissociation of the G-protein from the receptor, which then initiates a signaling cascade. The Hostos-Lincoln Academy SMART team (Students Modeling A Research Topic) modeled ligands in complex with B2AR using 3D printing technology. Supported by grants from the HHMI Precollege Program and the Camille and Henry Dreyfus Foundation. | ||
---- | |||
==='''Background Information'''=== | |||
[[Image:B2AR-Adernergic synapse.JPG|thumb|alt= Alt text| Adernergic Synapse |400px]] | |||
Adrenergic receptors are involved in activation of the sympathetic nervous system following sudden external stimuli. | Adrenergic receptors are involved in activation of the sympathetic nervous system following sudden external stimuli. After arrival of a nerve impulse, the neurotransmitter norepinephrine (NE) is released from the presynaptic terminal of the sympathetic neuron. NE is a tyrosine derived [[Image:B2AR-Norepinephrine.JPG|left|thumb|alt= Alt text| Norephrine |300px]] catecholamine containing an amino-hydroxyethyl and a catechol group. | ||
After arrival of a nerve impulse, the neurotransmitter norepinephrine (NE) is released from the presynaptic terminal of the sympathetic neuron. NE is a tyrosine derived catecholamine containing an amino-hydroxyethyl and a catechol group. | |||
NE binds to adrenergic receptors embedded in the postsynaptic effector cell membrane. | NE binds to adrenergic receptors embedded in the postsynaptic effector cell membrane. | ||
Following binding of NE, to either alpha or beta receptors, conformational changes in the receptor lead to a disassociation of the G protein from the cytoplasmic face of the receptor which activates a second messenger, initiating a signaling cascade. | Following binding of NE, to either alpha or beta receptors, conformational changes in the receptor lead to a disassociation of the G protein from the cytoplasmic face of the receptor which activates a second messenger, initiating a signaling cascade. | ||
{{clear}} | |||
---- | |||
{{clear}} | {{clear}} | ||
<applet load='3P0G' size='300' frame='true' align='right' scene='Sandbox_121/B2ar_struc/ | <applet load='3P0G' size='300' frame='true' align='right' scene='Sandbox_121/B2ar_struc/12' caption='B₂AR Active'/> | ||
| Line 36: | Line 33: | ||
B2AR is a single chain that crosses the lipid membrane 7 times from the extracellular to cytoplasmic surface. | B2AR is a single chain that crosses the lipid membrane 7 times from the extracellular to cytoplasmic surface. | ||
There are 3 extracellular loops and 3 intracellular loops. The <scene name='Sandbox_121/B2ar_struc/ | There are 3 extracellular loops and 3 intracellular loops. The <scene name='Sandbox_121/B2ar_struc/9'>binding pocket</scene> is located to the center of the extracellular surface. | ||
When B2AR is activated, the G-protein disassociates. A surrogate nanobody, <scene name='Sandbox_121/B2ar_struc/13'>Nb80</scene>, that is a camelid antibody produced to mimic the G-protein needed for an active state of the B2AR. | |||
Active B₂AR in complex with BI-167107: <scene name='Sandbox_121/B2ar_struc/7'>Polar</scene> and <scene name='Sandbox_121/B2ar_struc/8'>Hydrophobic</scene> Interactions | |||
{{clear}} | {{clear}} | ||
| Line 52: | Line 53: | ||
! scope="col" width="250" | Photo | ! scope="col" width="250" | Photo | ||
|- | |- | ||
| Isoproterenol || Isoproterenol is an agonist that is structurally similar to NE and readily binds to β₂AR with high affinity. Isoproterenol contains an isopropyl amino group and a catechol group. || [[Image:B2AR-Isoproterenol- | | Isoproterenol || Isoproterenol is an agonist that is structurally similar to NE and readily binds to β₂AR with high affinity. Isoproterenol contains an isopropyl amino group and a catechol group. || [[Image:B2AR-Isoproterenol-edited-structure.jpg|thumb|center|alt= Alt text| |300px]] || [[Image:Isoproterenol-Picture.JPG|thumb|center|alt= Alt text| |250px]] | ||
|- | |- | ||
| BI-167107 || The active state of β₂AR was crystallized using BI-1671071 . Although it is not a catecholamine, it is a full agonist. || [[Image:B2AR-BI-167107-Structure.JPG|thumb|center|alt= Alt text| |300px]] || [[Image:B2AR-BI-167107-Picture.JPG|thumb|center|alt= Alt text| |250px]] | | BI-167107 || The active state of β₂AR was crystallized using BI-1671071 . Although it is not a catecholamine, it is a full agonist. || [[Image:B2AR-BI-167107-Structure.JPG|thumb|center|alt= Alt text| |300px]] || [[Image:B2AR-BI-167107-Picture.JPG|thumb|center|alt= Alt text| |250px]] | ||
| Line 63: | Line 64: | ||
Notable differences between carazolol and both isoproterenol and the natural agonist norepinephrine are that: | Notable differences between carazolol and both isoproterenol and the natural agonist norepinephrine are that: | ||
(i) Carazolol lacks the hydroxyl groups thought to be necessary for the activation of β₂AR. | (i) Carazolol lacks the hydroxyl groups thought to be necessary for the activation of β₂AR. | ||
(ii) | (ii)The side chain of carazolol is two atoms (one carbon and one oxygen) longer in length from the amino group to the carbazole moiety. | ||
These are common characteristics of β₂AR antagonists. | These are common characteristics of β₂AR antagonists. | ||
---- | ---- | ||
[[Image:B2AR_Binding_Pocket_PolarInt_Act_In.JPG|right|thumb|alt= Alt text| The binding mode of isoproterenol and carazolol in B2AR. Hydrophobic residues are displayed in yellow. Polar interactions are displayed with residues in cyan, oxygen in red, and hydrogen in white. (a) A model of B2AR in its active state in complex with isoproterenol. | |||
(b) B2AR in its inactive state in complex with carazolol. |450px]] | |||
==='''Ligand Binding'''=== | ==='''Ligand Binding'''=== | ||
Ligands share several key interactions in the binding pocket including: | Ligands share several key interactions in the binding pocket including: | ||
| Line 83: | Line 83: | ||
in ECL2, Phe289 in TM6, and Phe290 inTM6. | in ECL2, Phe289 in TM6, and Phe290 inTM6. | ||
{{clear}} | {{clear}} | ||
---- | |||
==='''Conformational Change'''=== | ==='''Conformational Change'''=== | ||
<Structure load='Morph_2rh1_on_3p0g_all_atoms.pdb' size='500' frame='true' align='left' caption='Conformational Changes in B2AR from Inactive State(2rh1) to Active State(3p0g)' scene='Sandbox_254/B2ar_morph_ser_glu_arg/32'/> | |||
When an agonist is in the <scene name='Sandbox_254/B2ar_morph_ser_glu_arg/23'>binding pocket</scene> a 2.1Å inward movement of TM5 at Ser207 is observed. This bulge at ser207 allows for a hydrogen bond between the ligand and the receptor. This interaction appears to be a key event in activation. | |||
When an agonist is in the binding pocket a 2.1Å inward movement of TM5 at Ser207 is observed. This bulge at ser207 allows for a hydrogen bond between the ligand and the receptor. This interaction appears to be a key event in activation | |||
[[Image:B2AR-Binding_Pocket_OH.JPG|thumb|right|alt= Alt text| Models of isoproternol binding to two B2AR structures. (a) Inactive B2AR: 4.78Å distance between the catechol-OH of the ligand and Ser207 of TM5 is too large for a H-bond. (b) Active B2AR: A hydrogen bond distance of 2.17Å between the catechol-OH of the ligand and Ser207 on TM5 is shown. |450px]] | |||
[[Image:B2AR-Binding_Pocket_clash.JPG|thumb|right|alt= Alt text| Model of carazolol binding to B2AR structure. (a) Active B2AR: there is a steric clash between the ligand and Ser207 of TM5. (b)Inactive B2AR: carazolol in B2AR fits perfectly and blocks the agonist from entering the binding pocket. |450px]] | |||
{{clear}} | {{clear}} | ||
After the agonist binds, there is a rearrangement of interactions between residues located beneath the binding pocket that contributes to a rotation and outward movement of TM6 at Phe282. This change is associated with the breaking of the ionic lock between Glu268 in TM6 and Arg131 in TM3, resulting in an 11.4Å outward movement of the helix at the cytoplasmic face. | |||
==='''Molecular Morph'''=== | ==='''Molecular Morph'''=== | ||
The coordinates for molecular morphs between inactive state of B2AR (2rh1) and active state (3p0g) were generated using iPyMOL and eMovie (http://www.weizmann.ac.il/ISPC/eMovie.html). Morphs, a series of 10 linear interpolations between a starting and finishing model, are useful when viewing the transition of a conformational change. This model of B2AR using morphs should not be thought of as precise animation of conformational changes upon activation but rather as a comparison of the inactive state to the active state. | The coordinates for molecular morphs between inactive state of B2AR (2rh1) and active state (3p0g) were generated using iPyMOL and eMovie (http://www.weizmann.ac.il/ISPC/eMovie.html). Morphs, a series of 10 linear interpolations between a starting and finishing model, are useful when viewing the transition of a conformational change. This model of B2AR using morphs should not be thought of as precise animation of conformational changes upon activation but rather as a comparison of the inactive state to the active state. | ||
---- | |||
==='''Reference'''=== | |||
1. Vadim Cherezov, Daniel M. Rosenbaum, Michael A. Hanson, Søren G. F. Rasmussen, Foon Sun Thian, Tong Sun Kobilka, Hee-Jung Choi, Peter Kuhn, William I. Weis, Brian K. Kobilka, Raymond C. Stevens (2007). High Resolution Crystal Structure of an Engineered Human B2-Adrenergic G Protein- Coupled Receptor Science 318, 1258-1265. | |||
2.Søren G. F. Rasmussen, Hee-Jung Choi, Juan Jose Fung, Els Pardon, Paola Casarosa, Pil Seok Chae, Brian T. DeVree, Daniel M. Rosenbaum, Foon Sun Thian, Tong Sun Kobilka, Andreas Schnapp, Ingo Konetzki, Roger K. Sunahara,Samuel H. Gellman, Alexander Pautsch, Jan Steyaert, William I. Weis & Brian K. Kobilka (2011). Structure of a nanobody-stabilized active state of the B2 adrenoceptor Nature 469, 175-180. | |||
---- | |||
==='''Acknowledgements'''=== | |||
Camille and Henry Dreyfus Foundation, | |||
The Rockefeller University Center for Clinical and Translational Science, | |||
The Rockefeller University Science Outreach Program, | |||
Howard Hughes Medical Institute Pre-college Program, | |||
Center for BioMolecular Modeling, Milwaukee School of Engineering, | |||
The David A. Cofrin Center for Biomedical Information, | |||
in the HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College, | |||
---- | |||